Home ➤ Life Science ➤ Pharmaceuticals ➤ Influenza Vaccine Market
Influenza Vaccine Market
Published date: July 2024 • Formats:
Request Sample Schedule a Call

Global Influenza Vaccine Market By Type (Live Attenuated, Inactivated), By Valency (Quadrivalent, Trivalent), By Age Group (Pediatrics, Adults), By Route of Administration (Injection, Nasal Spray), By Distribution Channel (Hospital Pharmacy & Retail Pharmacy, Government Suppliers, Other Distribution Channels), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

  • Published date: July 2024
  • Report ID: 57384
  • Number of Pages: 272
  • Format:
  • keyboard_arrow_up
    • 1. Executive Summary
      • 1.1. Definition
      • 1.2. Taxonomy
      • 1.3. Research Scope
      • 1.4. Key Analysis
      • 1.5. Key Findings by Major Segments
      • 1.6. Top strategies by Major Players
    • 2. Global Influenza Vaccine Market Overview
      • 2.1. Influenza Vaccine Market Dynamics
        • 2.1.1. Drivers
        • 2.1.2. Opportunities
        • 2.1.3. Restraints
        • 2.1.4. Challenges
      • 2.2. Macro-economic Factors
      • 2.3. Regulatory Framework
      • 2.4. Market Investment Feasibility Index
      • 2.5. PEST Analysis
      • 2.6. PORTER’S Five Force Analysis
      • 2.7. Drivers & Restraints Impact Analysis
      • 2.8. Industry Chain Analysis
      • 2.9. Cost Structure Analysis
      • 2.10. Marketing Strategy
      • 2.11. Russia-Ukraine War Impact Analysis
      • 2.12. Opportunity Map Analysis
      • 2.13. Market Competition Scenario Analysis
      • 2.14. Product Life Cycle Analysis
      • 2.15. Opportunity Orbits
      • 2.16. Manufacturer Intensity Map
      • 2.17. Major Companies sales by Value & Volume
    • 3. Global Influenza Vaccine Market Analysis, Opportunity and Forecast, 2016-2032
      • 3.1. Global Influenza Vaccine Market Analysis, 2016-2021
      • 3.2. Global Influenza Vaccine Market Opportunity and Forecast, 2023-2032
      • 3.3. Global Influenza Vaccine Market Analysis, Opportunity and Forecast, By Type, 2016-2032
        • 3.3.1. Global Influenza Vaccine Market Analysis by Type: Introduction
        • 3.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Type, 2016-2032
        • 3.3.3. Live Attenuated
        • 3.3.4. Inactivated
      • 3.4. Global Influenza Vaccine Market Analysis, Opportunity and Forecast, By Valency, 2016-2032
        • 3.4.1. Global Influenza Vaccine Market Analysis by Valency: Introduction
        • 3.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Valency, 2016-2032
        • 3.4.3. Quadrivalent
        • 3.4.4. Trivalent
      • 3.5. Global Influenza Vaccine Market Analysis, Opportunity and Forecast, By Age Group, 2016-2032
        • 3.5.1. Global Influenza Vaccine Market Analysis by Age Group: Introduction
        • 3.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Age Group, 2016-2032
        • 3.5.3. Pediatrics
        • 3.5.4. Adults
      • 3.6. Global Influenza Vaccine Market Analysis, Opportunity and Forecast, By Route of Administration, 2016-2032
        • 3.6.1. Global Influenza Vaccine Market Analysis by Route of Administration: Introduction
        • 3.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Route of Administration, 2016-2032
        • 3.6.3. Injection
        • 3.6.4. Nasal Spray
      • 3.7. Global Influenza Vaccine Market Analysis, Opportunity and Forecast, By Distribution Channel, 2016-2032
        • 3.7.1. Global Influenza Vaccine Market Analysis by Distribution Channel: Introduction
        • 3.7.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Distribution Channel, 2016-2032
        • 3.7.3. Hospital Pharmacy & Retail Pharmacy
        • 3.7.4. Government Suppliers
        • 3.7.5. Other Distribution Channels
    • 4. North America Influenza Vaccine Market Analysis, Opportunity and Forecast, 2016-2032
      • 4.1. North America Influenza Vaccine Market Analysis, 2016-2021
      • 4.2. North America Influenza Vaccine Market Opportunity and Forecast, 2023-2032
      • 4.3. North America Influenza Vaccine Market Analysis, Opportunity and Forecast, By Type, 2016-2032
        • 4.3.1. North America Influenza Vaccine Market Analysis by Type: Introduction
        • 4.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Type, 2016-2032
        • 4.3.3. Live Attenuated
        • 4.3.4. Inactivated
      • 4.4. North America Influenza Vaccine Market Analysis, Opportunity and Forecast, By Valency, 2016-2032
        • 4.4.1. North America Influenza Vaccine Market Analysis by Valency: Introduction
        • 4.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Valency, 2016-2032
        • 4.4.3. Quadrivalent
        • 4.4.4. Trivalent
      • 4.5. North America Influenza Vaccine Market Analysis, Opportunity and Forecast, By Age Group, 2016-2032
        • 4.5.1. North America Influenza Vaccine Market Analysis by Age Group: Introduction
        • 4.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Age Group, 2016-2032
        • 4.5.3. Pediatrics
        • 4.5.4. Adults
      • 4.6. North America Influenza Vaccine Market Analysis, Opportunity and Forecast, By Route of Administration, 2016-2032
        • 4.6.1. North America Influenza Vaccine Market Analysis by Route of Administration: Introduction
        • 4.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Route of Administration, 2016-2032
        • 4.6.3. Injection
        • 4.6.4. Nasal Spray
      • 4.7. North America Influenza Vaccine Market Analysis, Opportunity and Forecast, By Distribution Channel, 2016-2032
        • 4.7.1. North America Influenza Vaccine Market Analysis by Distribution Channel: Introduction
        • 4.7.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Distribution Channel, 2016-2032
        • 4.7.3. Hospital Pharmacy & Retail Pharmacy
        • 4.7.4. Government Suppliers
        • 4.7.5. Other Distribution Channels
      • 4.8. North America Influenza Vaccine Market Analysis, Opportunity and Forecast, By Country , 2016-2032
        • 4.8.1. North America Influenza Vaccine Market Analysis by Country : Introduction
        • 4.8.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
          • 4.8.2.1. The US
          • 4.8.2.2. Canada
          • 4.8.2.3. Mexico
    • 5. Western Europe Influenza Vaccine Market Analysis, Opportunity and Forecast, 2016-2032
      • 5.1. Western Europe Influenza Vaccine Market Analysis, 2016-2021
      • 5.2. Western Europe Influenza Vaccine Market Opportunity and Forecast, 2023-2032
      • 5.3. Western Europe Influenza Vaccine Market Analysis, Opportunity and Forecast, By Type, 2016-2032
        • 5.3.1. Western Europe Influenza Vaccine Market Analysis by Type: Introduction
        • 5.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Type, 2016-2032
        • 5.3.3. Live Attenuated
        • 5.3.4. Inactivated
      • 5.4. Western Europe Influenza Vaccine Market Analysis, Opportunity and Forecast, By Valency, 2016-2032
        • 5.4.1. Western Europe Influenza Vaccine Market Analysis by Valency: Introduction
        • 5.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Valency, 2016-2032
        • 5.4.3. Quadrivalent
        • 5.4.4. Trivalent
      • 5.5. Western Europe Influenza Vaccine Market Analysis, Opportunity and Forecast, By Age Group, 2016-2032
        • 5.5.1. Western Europe Influenza Vaccine Market Analysis by Age Group: Introduction
        • 5.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Age Group, 2016-2032
        • 5.5.3. Pediatrics
        • 5.5.4. Adults
      • 5.6. Western Europe Influenza Vaccine Market Analysis, Opportunity and Forecast, By Route of Administration, 2016-2032
        • 5.6.1. Western Europe Influenza Vaccine Market Analysis by Route of Administration: Introduction
        • 5.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Route of Administration, 2016-2032
        • 5.6.3. Injection
        • 5.6.4. Nasal Spray
      • 5.7. Western Europe Influenza Vaccine Market Analysis, Opportunity and Forecast, By Distribution Channel, 2016-2032
        • 5.7.1. Western Europe Influenza Vaccine Market Analysis by Distribution Channel: Introduction
        • 5.7.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Distribution Channel, 2016-2032
        • 5.7.3. Hospital Pharmacy & Retail Pharmacy
        • 5.7.4. Government Suppliers
        • 5.7.5. Other Distribution Channels
      • 5.8. Western Europe Influenza Vaccine Market Analysis, Opportunity and Forecast, By Country , 2016-2032
        • 5.8.1. Western Europe Influenza Vaccine Market Analysis by Country : Introduction
        • 5.8.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
          • 5.8.2.1. Germany
          • 5.8.2.2. France
          • 5.8.2.3. The UK
          • 5.8.2.4. Spain
          • 5.8.2.5. Italy
          • 5.8.2.6. Portugal
          • 5.8.2.7. Ireland
          • 5.8.2.8. Austria
          • 5.8.2.9. Switzerland
          • 5.8.2.10. Benelux
          • 5.8.2.11. Nordic
          • 5.8.2.12. Rest of Western Europe
    • 6. Eastern Europe Influenza Vaccine Market Analysis, Opportunity and Forecast, 2016-2032
      • 6.1. Eastern Europe Influenza Vaccine Market Analysis, 2016-2021
      • 6.2. Eastern Europe Influenza Vaccine Market Opportunity and Forecast, 2023-2032
      • 6.3. Eastern Europe Influenza Vaccine Market Analysis, Opportunity and Forecast, By Type, 2016-2032
        • 6.3.1. Eastern Europe Influenza Vaccine Market Analysis by Type: Introduction
        • 6.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Type, 2016-2032
        • 6.3.3. Live Attenuated
        • 6.3.4. Inactivated
      • 6.4. Eastern Europe Influenza Vaccine Market Analysis, Opportunity and Forecast, By Valency, 2016-2032
        • 6.4.1. Eastern Europe Influenza Vaccine Market Analysis by Valency: Introduction
        • 6.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Valency, 2016-2032
        • 6.4.3. Quadrivalent
        • 6.4.4. Trivalent
      • 6.5. Eastern Europe Influenza Vaccine Market Analysis, Opportunity and Forecast, By Age Group, 2016-2032
        • 6.5.1. Eastern Europe Influenza Vaccine Market Analysis by Age Group: Introduction
        • 6.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Age Group, 2016-2032
        • 6.5.3. Pediatrics
        • 6.5.4. Adults
      • 6.6. Eastern Europe Influenza Vaccine Market Analysis, Opportunity and Forecast, By Route of Administration, 2016-2032
        • 6.6.1. Eastern Europe Influenza Vaccine Market Analysis by Route of Administration: Introduction
        • 6.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Route of Administration, 2016-2032
        • 6.6.3. Injection
        • 6.6.4. Nasal Spray
      • 6.7. Eastern Europe Influenza Vaccine Market Analysis, Opportunity and Forecast, By Distribution Channel, 2016-2032
        • 6.7.1. Eastern Europe Influenza Vaccine Market Analysis by Distribution Channel: Introduction
        • 6.7.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Distribution Channel, 2016-2032
        • 6.7.3. Hospital Pharmacy & Retail Pharmacy
        • 6.7.4. Government Suppliers
        • 6.7.5. Other Distribution Channels
      • 6.8. Eastern Europe Influenza Vaccine Market Analysis, Opportunity and Forecast, By Country , 2016-2032
        • 6.8.1. Eastern Europe Influenza Vaccine Market Analysis by Country : Introduction
        • 6.8.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
          • 6.8.2.1. Russia
          • 6.8.2.2. Poland
          • 6.8.2.3. The Czech Republic
          • 6.8.2.4. Greece
          • 6.8.2.5. Rest of Eastern Europe
    • 7. APAC Influenza Vaccine Market Analysis, Opportunity and Forecast, 2016-2032
      • 7.1. APAC Influenza Vaccine Market Analysis, 2016-2021
      • 7.2. APAC Influenza Vaccine Market Opportunity and Forecast, 2023-2032
      • 7.3. APAC Influenza Vaccine Market Analysis, Opportunity and Forecast, By Type, 2016-2032
        • 7.3.1. APAC Influenza Vaccine Market Analysis by Type: Introduction
        • 7.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Type, 2016-2032
        • 7.3.3. Live Attenuated
        • 7.3.4. Inactivated
      • 7.4. APAC Influenza Vaccine Market Analysis, Opportunity and Forecast, By Valency, 2016-2032
        • 7.4.1. APAC Influenza Vaccine Market Analysis by Valency: Introduction
        • 7.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Valency, 2016-2032
        • 7.4.3. Quadrivalent
        • 7.4.4. Trivalent
      • 7.5. APAC Influenza Vaccine Market Analysis, Opportunity and Forecast, By Age Group, 2016-2032
        • 7.5.1. APAC Influenza Vaccine Market Analysis by Age Group: Introduction
        • 7.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Age Group, 2016-2032
        • 7.5.3. Pediatrics
        • 7.5.4. Adults
      • 7.6. APAC Influenza Vaccine Market Analysis, Opportunity and Forecast, By Route of Administration, 2016-2032
        • 7.6.1. APAC Influenza Vaccine Market Analysis by Route of Administration: Introduction
        • 7.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Route of Administration, 2016-2032
        • 7.6.3. Injection
        • 7.6.4. Nasal Spray
      • 7.7. APAC Influenza Vaccine Market Analysis, Opportunity and Forecast, By Distribution Channel, 2016-2032
        • 7.7.1. APAC Influenza Vaccine Market Analysis by Distribution Channel: Introduction
        • 7.7.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Distribution Channel, 2016-2032
        • 7.7.3. Hospital Pharmacy & Retail Pharmacy
        • 7.7.4. Government Suppliers
        • 7.7.5. Other Distribution Channels
      • 7.8. APAC Influenza Vaccine Market Analysis, Opportunity and Forecast, By Country , 2016-2032
        • 7.8.1. APAC Influenza Vaccine Market Analysis by Country : Introduction
        • 7.8.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
          • 7.8.2.1. China
          • 7.8.2.2. Japan
          • 7.8.2.3. South Korea
          • 7.8.2.4. India
          • 7.8.2.5. Australia & New Zeland
          • 7.8.2.6. Indonesia
          • 7.8.2.7. Malaysia
          • 7.8.2.8. Philippines
          • 7.8.2.9. Singapore
          • 7.8.2.10. Thailand
          • 7.8.2.11. Vietnam
          • 7.8.2.12. Rest of APAC
    • 8. Latin America Influenza Vaccine Market Analysis, Opportunity and Forecast, 2016-2032
      • 8.1. Latin America Influenza Vaccine Market Analysis, 2016-2021
      • 8.2. Latin America Influenza Vaccine Market Opportunity and Forecast, 2023-2032
      • 8.3. Latin America Influenza Vaccine Market Analysis, Opportunity and Forecast, By Type, 2016-2032
        • 8.3.1. Latin America Influenza Vaccine Market Analysis by Type: Introduction
        • 8.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Type, 2016-2032
        • 8.3.3. Live Attenuated
        • 8.3.4. Inactivated
      • 8.4. Latin America Influenza Vaccine Market Analysis, Opportunity and Forecast, By Valency, 2016-2032
        • 8.4.1. Latin America Influenza Vaccine Market Analysis by Valency: Introduction
        • 8.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Valency, 2016-2032
        • 8.4.3. Quadrivalent
        • 8.4.4. Trivalent
      • 8.5. Latin America Influenza Vaccine Market Analysis, Opportunity and Forecast, By Age Group, 2016-2032
        • 8.5.1. Latin America Influenza Vaccine Market Analysis by Age Group: Introduction
        • 8.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Age Group, 2016-2032
        • 8.5.3. Pediatrics
        • 8.5.4. Adults
      • 8.6. Latin America Influenza Vaccine Market Analysis, Opportunity and Forecast, By Route of Administration, 2016-2032
        • 8.6.1. Latin America Influenza Vaccine Market Analysis by Route of Administration: Introduction
        • 8.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Route of Administration, 2016-2032
        • 8.6.3. Injection
        • 8.6.4. Nasal Spray
      • 8.7. Latin America Influenza Vaccine Market Analysis, Opportunity and Forecast, By Distribution Channel, 2016-2032
        • 8.7.1. Latin America Influenza Vaccine Market Analysis by Distribution Channel: Introduction
        • 8.7.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Distribution Channel, 2016-2032
        • 8.7.3. Hospital Pharmacy & Retail Pharmacy
        • 8.7.4. Government Suppliers
        • 8.7.5. Other Distribution Channels
      • 8.8. Latin America Influenza Vaccine Market Analysis, Opportunity and Forecast, By Country , 2016-2032
        • 8.8.1. Latin America Influenza Vaccine Market Analysis by Country : Introduction
        • 8.8.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
          • 8.8.2.1. Brazil
          • 8.8.2.2. Colombia
          • 8.8.2.3. Chile
          • 8.8.2.4. Argentina
          • 8.8.2.5. Costa Rica
          • 8.8.2.6. Rest of Latin America
    • 9. Middle East & Africa Influenza Vaccine Market Analysis, Opportunity and Forecast, 2016-2032
      • 9.1. Middle East & Africa Influenza Vaccine Market Analysis, 2016-2021
      • 9.2. Middle East & Africa Influenza Vaccine Market Opportunity and Forecast, 2023-2032
      • 9.3. Middle East & Africa Influenza Vaccine Market Analysis, Opportunity and Forecast, By Type, 2016-2032
        • 9.3.1. Middle East & Africa Influenza Vaccine Market Analysis by Type: Introduction
        • 9.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Type, 2016-2032
        • 9.3.3. Live Attenuated
        • 9.3.4. Inactivated
      • 9.4. Middle East & Africa Influenza Vaccine Market Analysis, Opportunity and Forecast, By Valency, 2016-2032
        • 9.4.1. Middle East & Africa Influenza Vaccine Market Analysis by Valency: Introduction
        • 9.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Valency, 2016-2032
        • 9.4.3. Quadrivalent
        • 9.4.4. Trivalent
      • 9.5. Middle East & Africa Influenza Vaccine Market Analysis, Opportunity and Forecast, By Age Group, 2016-2032
        • 9.5.1. Middle East & Africa Influenza Vaccine Market Analysis by Age Group: Introduction
        • 9.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Age Group, 2016-2032
        • 9.5.3. Pediatrics
        • 9.5.4. Adults
      • 9.6. Middle East & Africa Influenza Vaccine Market Analysis, Opportunity and Forecast, By Route of Administration, 2016-2032
        • 9.6.1. Middle East & Africa Influenza Vaccine Market Analysis by Route of Administration: Introduction
        • 9.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Route of Administration, 2016-2032
        • 9.6.3. Injection
        • 9.6.4. Nasal Spray
      • 9.7. Middle East & Africa Influenza Vaccine Market Analysis, Opportunity and Forecast, By Distribution Channel, 2016-2032
        • 9.7.1. Middle East & Africa Influenza Vaccine Market Analysis by Distribution Channel: Introduction
        • 9.7.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Distribution Channel, 2016-2032
        • 9.7.3. Hospital Pharmacy & Retail Pharmacy
        • 9.7.4. Government Suppliers
        • 9.7.5. Other Distribution Channels
      • 9.8. Middle East & Africa Influenza Vaccine Market Analysis, Opportunity and Forecast, By Country , 2016-2032
        • 9.8.1. Middle East & Africa Influenza Vaccine Market Analysis by Country : Introduction
        • 9.8.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
          • 9.8.2.1. Algeria
          • 9.8.2.2. Egypt
          • 9.8.2.3. Israel
          • 9.8.2.4. Kuwait
          • 9.8.2.5. Nigeria
          • 9.8.2.6. Saudi Arabia
          • 9.8.2.7. South Africa
          • 9.8.2.8. Turkey
          • 9.8.2.9. The UAE
          • 9.8.2.10. Rest of MEA
    • 10. Global Influenza Vaccine Market Analysis, Opportunity and Forecast, By Region , 2016-2032
      • 10.1. Global Influenza Vaccine Market Analysis by Region : Introduction
      • 10.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Region , 2016-2032
        • 10.2.1. North America
        • 10.2.2. Western Europe
        • 10.2.3. Eastern Europe
        • 10.2.4. APAC
        • 10.2.5. Latin America
        • 10.2.6. Middle East & Africa
    • 11. Global Influenza Vaccine Market Competitive Landscape, Market Share Analysis, and Company Profiles
      • 11.1. Market Share Analysis
      • 11.2. Company Profiles
      • 11.3. Sanofi S.A.
        • 11.3.1. Company Overview
        • 11.3.2. Financial Highlights
        • 11.3.3. Product Portfolio
        • 11.3.4. SWOT Analysis
        • 11.3.5. Key Strategies and Developments
      • 11.4. AstraZeneca plc
        • 11.4.1. Company Overview
        • 11.4.2. Financial Highlights
        • 11.4.3. Product Portfolio
        • 11.4.4. SWOT Analysis
        • 11.4.5. Key Strategies and Developments
      • 11.5. CSL Limited
        • 11.5.1. Company Overview
        • 11.5.2. Financial Highlights
        • 11.5.3. Product Portfolio
        • 11.5.4. SWOT Analysis
        • 11.5.5. Key Strategies and Developments
      • 11.6. BIKEN Co, Ltd.
        • 11.6.1. Company Overview
        • 11.6.2. Financial Highlights
        • 11.6.3. Product Portfolio
        • 11.6.4. SWOT Analysis
        • 11.6.5. Key Strategies and Developments
      • 11.7. GlaxoSmithKline plc
        • 11.7.1. Company Overview
        • 11.7.2. Financial Highlights
        • 11.7.3. Product Portfolio
        • 11.7.4. SWOT Analysis
        • 11.7.5. Key Strategies and Developments
      • 11.8. Adeor Medical AG
        • 11.8.1. Company Overview
        • 11.8.2. Financial Highlights
        • 11.8.3. Product Portfolio
        • 11.8.4. SWOT Analysis
        • 11.8.5. Key Strategies and Developments
      • 11.9. Sinovac Biotech Ltd.
        • 11.9.1. Company Overview
        • 11.9.2. Financial Highlights
        • 11.9.3. Product Portfolio
        • 11.9.4. SWOT Analysis
        • 11.9.5. Key Strategies and Developments
      • 11.10. Viatris Inc.
        • 11.10.1. Company Overview
        • 11.10.2. Financial Highlights
        • 11.10.3. Product Portfolio
        • 11.10.4. SWOT Analysis
        • 11.10.5. Key Strategies and Developments
      • 11.11. Merck & Co, Inc.
        • 11.11.1. Company Overview
        • 11.11.2. Financial Highlights
        • 11.11.3. Product Portfolio
        • 11.11.4. SWOT Analysis
        • 11.11.5. Key Strategies and Developments
      • 11.12. EMERGEX VACCINES
        • 11.12.1. Company Overview
        • 11.12.2. Financial Highlights
        • 11.12.3. Product Portfolio
        • 11.12.4. SWOT Analysis
        • 11.12.5. Key Strategies and Developments
      • 11.13. Other Key Players
        • 11.13.1. Company Overview
        • 11.13.2. Financial Highlights
        • 11.13.3. Product Portfolio
        • 11.13.4. SWOT Analysis
        • 11.13.5. Key Strategies and Developments
    • 12. Assumptions and Acronyms
    • 13. Research Methodology
    • 14. Contact
    • List of Figures
      • Figure 1: Global Influenza Vaccine Market Revenue (US$ Mn) Market Share by Type in 2022
      • Figure 2: Global Influenza Vaccine Market Attractiveness Analysis by Type, 2016-2032
      • Figure 3: Global Influenza Vaccine Market Revenue (US$ Mn) Market Share by Valencyin 2022
      • Figure 4: Global Influenza Vaccine Market Attractiveness Analysis by Valency, 2016-2032
      • Figure 5: Global Influenza Vaccine Market Revenue (US$ Mn) Market Share by Age Groupin 2022
      • Figure 6: Global Influenza Vaccine Market Attractiveness Analysis by Age Group, 2016-2032
      • Figure 7: Global Influenza Vaccine Market Revenue (US$ Mn) Market Share by Route of Administrationin 2022
      • Figure 8: Global Influenza Vaccine Market Attractiveness Analysis by Route of Administration, 2016-2032
      • Figure 9: Global Influenza Vaccine Market Revenue (US$ Mn) Market Share by Distribution Channelin 2022
      • Figure 10: Global Influenza Vaccine Market Attractiveness Analysis by Distribution Channel, 2016-2032
      • Figure 11: Global Influenza Vaccine Market Revenue (US$ Mn) Market Share by Region in 2022
      • Figure 12: Global Influenza Vaccine Market Attractiveness Analysis by Region, 2016-2032
      • Figure 13: Global Influenza Vaccine Market Revenue (US$ Mn) (2016-2032)
      • Figure 14: Global Influenza Vaccine Market Revenue (US$ Mn) Comparison by Region (2016-2032)
      • Figure 15: Global Influenza Vaccine Market Revenue (US$ Mn) Comparison by Type (2016-2032)
      • Figure 16: Global Influenza Vaccine Market Revenue (US$ Mn) Comparison by Valency (2016-2032)
      • Figure 17: Global Influenza Vaccine Market Revenue (US$ Mn) Comparison by Age Group (2016-2032)
      • Figure 18: Global Influenza Vaccine Market Revenue (US$ Mn) Comparison by Route of Administration (2016-2032)
      • Figure 19: Global Influenza Vaccine Market Revenue (US$ Mn) Comparison by Distribution Channel (2016-2032)
      • Figure 20: Global Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Region (2016-2032)
      • Figure 21: Global Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
      • Figure 22: Global Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Valency (2016-2032)
      • Figure 23: Global Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Age Group (2016-2032)
      • Figure 24: Global Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Route of Administration (2016-2032)
      • Figure 25: Global Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Distribution Channel (2016-2032)
      • Figure 26: Global Influenza Vaccine Market Share Comparison by Region (2016-2032)
      • Figure 27: Global Influenza Vaccine Market Share Comparison by Type (2016-2032)
      • Figure 28: Global Influenza Vaccine Market Share Comparison by Valency (2016-2032)
      • Figure 29: Global Influenza Vaccine Market Share Comparison by Age Group (2016-2032)
      • Figure 30: Global Influenza Vaccine Market Share Comparison by Route of Administration (2016-2032)
      • Figure 31: Global Influenza Vaccine Market Share Comparison by Distribution Channel (2016-2032)
      • Figure 32: North America Influenza Vaccine Market Revenue (US$ Mn) Market Share by Typein 2022
      • Figure 33: North America Influenza Vaccine Market Attractiveness Analysis by Type, 2016-2032
      • Figure 34: North America Influenza Vaccine Market Revenue (US$ Mn) Market Share by Valencyin 2022
      • Figure 35: North America Influenza Vaccine Market Attractiveness Analysis by Valency, 2016-2032
      • Figure 36: North America Influenza Vaccine Market Revenue (US$ Mn) Market Share by Age Groupin 2022
      • Figure 37: North America Influenza Vaccine Market Attractiveness Analysis by Age Group, 2016-2032
      • Figure 38: North America Influenza Vaccine Market Revenue (US$ Mn) Market Share by Route of Administrationin 2022
      • Figure 39: North America Influenza Vaccine Market Attractiveness Analysis by Route of Administration, 2016-2032
      • Figure 40: North America Influenza Vaccine Market Revenue (US$ Mn) Market Share by Distribution Channelin 2022
      • Figure 41: North America Influenza Vaccine Market Attractiveness Analysis by Distribution Channel, 2016-2032
      • Figure 42: North America Influenza Vaccine Market Revenue (US$ Mn) Market Share by Country in 2022
      • Figure 43: North America Influenza Vaccine Market Attractiveness Analysis by Country, 2016-2032
      • Figure 44: North America Influenza Vaccine Market Revenue (US$ Mn) (2016-2032)
      • Figure 45: North America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Figure 46: North America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Type (2016-2032)
      • Figure 47: North America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Valency (2016-2032)
      • Figure 48: North America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Age Group (2016-2032)
      • Figure 49: North America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Route of Administration (2016-2032)
      • Figure 50: North America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Distribution Channel (2016-2032)
      • Figure 51: North America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
      • Figure 52: North America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
      • Figure 53: North America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Valency (2016-2032)
      • Figure 54: North America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Age Group (2016-2032)
      • Figure 55: North America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Route of Administration (2016-2032)
      • Figure 56: North America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Distribution Channel (2016-2032)
      • Figure 57: North America Influenza Vaccine Market Share Comparison by Country (2016-2032)
      • Figure 58: North America Influenza Vaccine Market Share Comparison by Type (2016-2032)
      • Figure 59: North America Influenza Vaccine Market Share Comparison by Valency (2016-2032)
      • Figure 60: North America Influenza Vaccine Market Share Comparison by Age Group (2016-2032)
      • Figure 61: North America Influenza Vaccine Market Share Comparison by Route of Administration (2016-2032)
      • Figure 62: North America Influenza Vaccine Market Share Comparison by Distribution Channel (2016-2032)
      • Figure 63: Western Europe Influenza Vaccine Market Revenue (US$ Mn) Market Share by Typein 2022
      • Figure 64: Western Europe Influenza Vaccine Market Attractiveness Analysis by Type, 2016-2032
      • Figure 65: Western Europe Influenza Vaccine Market Revenue (US$ Mn) Market Share by Valencyin 2022
      • Figure 66: Western Europe Influenza Vaccine Market Attractiveness Analysis by Valency, 2016-2032
      • Figure 67: Western Europe Influenza Vaccine Market Revenue (US$ Mn) Market Share by Age Groupin 2022
      • Figure 68: Western Europe Influenza Vaccine Market Attractiveness Analysis by Age Group, 2016-2032
      • Figure 69: Western Europe Influenza Vaccine Market Revenue (US$ Mn) Market Share by Route of Administrationin 2022
      • Figure 70: Western Europe Influenza Vaccine Market Attractiveness Analysis by Route of Administration, 2016-2032
      • Figure 71: Western Europe Influenza Vaccine Market Revenue (US$ Mn) Market Share by Distribution Channelin 2022
      • Figure 72: Western Europe Influenza Vaccine Market Attractiveness Analysis by Distribution Channel, 2016-2032
      • Figure 73: Western Europe Influenza Vaccine Market Revenue (US$ Mn) Market Share by Country in 2022
      • Figure 74: Western Europe Influenza Vaccine Market Attractiveness Analysis by Country, 2016-2032
      • Figure 75: Western Europe Influenza Vaccine Market Revenue (US$ Mn) (2016-2032)
      • Figure 76: Western Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Figure 77: Western Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Type (2016-2032)
      • Figure 78: Western Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Valency (2016-2032)
      • Figure 79: Western Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Age Group (2016-2032)
      • Figure 80: Western Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Route of Administration (2016-2032)
      • Figure 81: Western Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Distribution Channel (2016-2032)
      • Figure 82: Western Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
      • Figure 83: Western Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
      • Figure 84: Western Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Valency (2016-2032)
      • Figure 85: Western Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Age Group (2016-2032)
      • Figure 86: Western Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Route of Administration (2016-2032)
      • Figure 87: Western Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Distribution Channel (2016-2032)
      • Figure 88: Western Europe Influenza Vaccine Market Share Comparison by Country (2016-2032)
      • Figure 89: Western Europe Influenza Vaccine Market Share Comparison by Type (2016-2032)
      • Figure 90: Western Europe Influenza Vaccine Market Share Comparison by Valency (2016-2032)
      • Figure 91: Western Europe Influenza Vaccine Market Share Comparison by Age Group (2016-2032)
      • Figure 92: Western Europe Influenza Vaccine Market Share Comparison by Route of Administration (2016-2032)
      • Figure 93: Western Europe Influenza Vaccine Market Share Comparison by Distribution Channel (2016-2032)
      • Figure 94: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) Market Share by Typein 2022
      • Figure 95: Eastern Europe Influenza Vaccine Market Attractiveness Analysis by Type, 2016-2032
      • Figure 96: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) Market Share by Valencyin 2022
      • Figure 97: Eastern Europe Influenza Vaccine Market Attractiveness Analysis by Valency, 2016-2032
      • Figure 98: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) Market Share by Age Groupin 2022
      • Figure 99: Eastern Europe Influenza Vaccine Market Attractiveness Analysis by Age Group, 2016-2032
      • Figure 100: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) Market Share by Route of Administrationin 2022
      • Figure 101: Eastern Europe Influenza Vaccine Market Attractiveness Analysis by Route of Administration, 2016-2032
      • Figure 102: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) Market Share by Distribution Channelin 2022
      • Figure 103: Eastern Europe Influenza Vaccine Market Attractiveness Analysis by Distribution Channel, 2016-2032
      • Figure 104: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) Market Share by Country in 2022
      • Figure 105: Eastern Europe Influenza Vaccine Market Attractiveness Analysis by Country, 2016-2032
      • Figure 106: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) (2016-2032)
      • Figure 107: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Figure 108: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Type (2016-2032)
      • Figure 109: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Valency (2016-2032)
      • Figure 110: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Age Group (2016-2032)
      • Figure 111: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Route of Administration (2016-2032)
      • Figure 112: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Distribution Channel (2016-2032)
      • Figure 113: Eastern Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
      • Figure 114: Eastern Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
      • Figure 115: Eastern Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Valency (2016-2032)
      • Figure 116: Eastern Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Age Group (2016-2032)
      • Figure 117: Eastern Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Route of Administration (2016-2032)
      • Figure 118: Eastern Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Distribution Channel (2016-2032)
      • Figure 119: Eastern Europe Influenza Vaccine Market Share Comparison by Country (2016-2032)
      • Figure 120: Eastern Europe Influenza Vaccine Market Share Comparison by Type (2016-2032)
      • Figure 121: Eastern Europe Influenza Vaccine Market Share Comparison by Valency (2016-2032)
      • Figure 122: Eastern Europe Influenza Vaccine Market Share Comparison by Age Group (2016-2032)
      • Figure 123: Eastern Europe Influenza Vaccine Market Share Comparison by Route of Administration (2016-2032)
      • Figure 124: Eastern Europe Influenza Vaccine Market Share Comparison by Distribution Channel (2016-2032)
      • Figure 125: APAC Influenza Vaccine Market Revenue (US$ Mn) Market Share by Typein 2022
      • Figure 126: APAC Influenza Vaccine Market Attractiveness Analysis by Type, 2016-2032
      • Figure 127: APAC Influenza Vaccine Market Revenue (US$ Mn) Market Share by Valencyin 2022
      • Figure 128: APAC Influenza Vaccine Market Attractiveness Analysis by Valency, 2016-2032
      • Figure 129: APAC Influenza Vaccine Market Revenue (US$ Mn) Market Share by Age Groupin 2022
      • Figure 130: APAC Influenza Vaccine Market Attractiveness Analysis by Age Group, 2016-2032
      • Figure 131: APAC Influenza Vaccine Market Revenue (US$ Mn) Market Share by Route of Administrationin 2022
      • Figure 132: APAC Influenza Vaccine Market Attractiveness Analysis by Route of Administration, 2016-2032
      • Figure 133: APAC Influenza Vaccine Market Revenue (US$ Mn) Market Share by Distribution Channelin 2022
      • Figure 134: APAC Influenza Vaccine Market Attractiveness Analysis by Distribution Channel, 2016-2032
      • Figure 135: APAC Influenza Vaccine Market Revenue (US$ Mn) Market Share by Country in 2022
      • Figure 136: APAC Influenza Vaccine Market Attractiveness Analysis by Country, 2016-2032
      • Figure 137: APAC Influenza Vaccine Market Revenue (US$ Mn) (2016-2032)
      • Figure 138: APAC Influenza Vaccine Market Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Figure 139: APAC Influenza Vaccine Market Revenue (US$ Mn) Comparison by Type (2016-2032)
      • Figure 140: APAC Influenza Vaccine Market Revenue (US$ Mn) Comparison by Valency (2016-2032)
      • Figure 141: APAC Influenza Vaccine Market Revenue (US$ Mn) Comparison by Age Group (2016-2032)
      • Figure 142: APAC Influenza Vaccine Market Revenue (US$ Mn) Comparison by Route of Administration (2016-2032)
      • Figure 143: APAC Influenza Vaccine Market Revenue (US$ Mn) Comparison by Distribution Channel (2016-2032)
      • Figure 144: APAC Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
      • Figure 145: APAC Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
      • Figure 146: APAC Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Valency (2016-2032)
      • Figure 147: APAC Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Age Group (2016-2032)
      • Figure 148: APAC Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Route of Administration (2016-2032)
      • Figure 149: APAC Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Distribution Channel (2016-2032)
      • Figure 150: APAC Influenza Vaccine Market Share Comparison by Country (2016-2032)
      • Figure 151: APAC Influenza Vaccine Market Share Comparison by Type (2016-2032)
      • Figure 152: APAC Influenza Vaccine Market Share Comparison by Valency (2016-2032)
      • Figure 153: APAC Influenza Vaccine Market Share Comparison by Age Group (2016-2032)
      • Figure 154: APAC Influenza Vaccine Market Share Comparison by Route of Administration (2016-2032)
      • Figure 155: APAC Influenza Vaccine Market Share Comparison by Distribution Channel (2016-2032)
      • Figure 156: Latin America Influenza Vaccine Market Revenue (US$ Mn) Market Share by Typein 2022
      • Figure 157: Latin America Influenza Vaccine Market Attractiveness Analysis by Type, 2016-2032
      • Figure 158: Latin America Influenza Vaccine Market Revenue (US$ Mn) Market Share by Valencyin 2022
      • Figure 159: Latin America Influenza Vaccine Market Attractiveness Analysis by Valency, 2016-2032
      • Figure 160: Latin America Influenza Vaccine Market Revenue (US$ Mn) Market Share by Age Groupin 2022
      • Figure 161: Latin America Influenza Vaccine Market Attractiveness Analysis by Age Group, 2016-2032
      • Figure 162: Latin America Influenza Vaccine Market Revenue (US$ Mn) Market Share by Route of Administrationin 2022
      • Figure 163: Latin America Influenza Vaccine Market Attractiveness Analysis by Route of Administration, 2016-2032
      • Figure 164: Latin America Influenza Vaccine Market Revenue (US$ Mn) Market Share by Distribution Channelin 2022
      • Figure 165: Latin America Influenza Vaccine Market Attractiveness Analysis by Distribution Channel, 2016-2032
      • Figure 166: Latin America Influenza Vaccine Market Revenue (US$ Mn) Market Share by Country in 2022
      • Figure 167: Latin America Influenza Vaccine Market Attractiveness Analysis by Country, 2016-2032
      • Figure 168: Latin America Influenza Vaccine Market Revenue (US$ Mn) (2016-2032)
      • Figure 169: Latin America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Figure 170: Latin America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Type (2016-2032)
      • Figure 171: Latin America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Valency (2016-2032)
      • Figure 172: Latin America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Age Group (2016-2032)
      • Figure 173: Latin America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Route of Administration (2016-2032)
      • Figure 174: Latin America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Distribution Channel (2016-2032)
      • Figure 175: Latin America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
      • Figure 176: Latin America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
      • Figure 177: Latin America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Valency (2016-2032)
      • Figure 178: Latin America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Age Group (2016-2032)
      • Figure 179: Latin America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Route of Administration (2016-2032)
      • Figure 180: Latin America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Distribution Channel (2016-2032)
      • Figure 181: Latin America Influenza Vaccine Market Share Comparison by Country (2016-2032)
      • Figure 182: Latin America Influenza Vaccine Market Share Comparison by Type (2016-2032)
      • Figure 183: Latin America Influenza Vaccine Market Share Comparison by Valency (2016-2032)
      • Figure 184: Latin America Influenza Vaccine Market Share Comparison by Age Group (2016-2032)
      • Figure 185: Latin America Influenza Vaccine Market Share Comparison by Route of Administration (2016-2032)
      • Figure 186: Latin America Influenza Vaccine Market Share Comparison by Distribution Channel (2016-2032)
      • Figure 187: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) Market Share by Typein 2022
      • Figure 188: Middle East & Africa Influenza Vaccine Market Attractiveness Analysis by Type, 2016-2032
      • Figure 189: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) Market Share by Valencyin 2022
      • Figure 190: Middle East & Africa Influenza Vaccine Market Attractiveness Analysis by Valency, 2016-2032
      • Figure 191: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) Market Share by Age Groupin 2022
      • Figure 192: Middle East & Africa Influenza Vaccine Market Attractiveness Analysis by Age Group, 2016-2032
      • Figure 193: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) Market Share by Route of Administrationin 2022
      • Figure 194: Middle East & Africa Influenza Vaccine Market Attractiveness Analysis by Route of Administration, 2016-2032
      • Figure 195: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) Market Share by Distribution Channelin 2022
      • Figure 196: Middle East & Africa Influenza Vaccine Market Attractiveness Analysis by Distribution Channel, 2016-2032
      • Figure 197: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) Market Share by Country in 2022
      • Figure 198: Middle East & Africa Influenza Vaccine Market Attractiveness Analysis by Country, 2016-2032
      • Figure 199: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) (2016-2032)
      • Figure 200: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Figure 201: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) Comparison by Type (2016-2032)
      • Figure 202: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) Comparison by Valency (2016-2032)
      • Figure 203: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) Comparison by Age Group (2016-2032)
      • Figure 204: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) Comparison by Route of Administration (2016-2032)
      • Figure 205: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) Comparison by Distribution Channel (2016-2032)
      • Figure 206: Middle East & Africa Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
      • Figure 207: Middle East & Africa Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
      • Figure 208: Middle East & Africa Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Valency (2016-2032)
      • Figure 209: Middle East & Africa Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Age Group (2016-2032)
      • Figure 210: Middle East & Africa Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Route of Administration (2016-2032)
      • Figure 211: Middle East & Africa Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Distribution Channel (2016-2032)
      • Figure 212: Middle East & Africa Influenza Vaccine Market Share Comparison by Country (2016-2032)
      • Figure 213: Middle East & Africa Influenza Vaccine Market Share Comparison by Type (2016-2032)
      • Figure 214: Middle East & Africa Influenza Vaccine Market Share Comparison by Valency (2016-2032)
      • Figure 215: Middle East & Africa Influenza Vaccine Market Share Comparison by Age Group (2016-2032)
      • Figure 216: Middle East & Africa Influenza Vaccine Market Share Comparison by Route of Administration (2016-2032)
      • Figure 217: Middle East & Africa Influenza Vaccine Market Share Comparison by Distribution Channel (2016-2032)

       

    • List of Tables
      • Table 1: Global Influenza Vaccine Market Comparison by Type (2016-2032)
      • Table 2: Global Influenza Vaccine Market Comparison by Valency (2016-2032)
      • Table 3: Global Influenza Vaccine Market Comparison by Age Group (2016-2032)
      • Table 4: Global Influenza Vaccine Market Comparison by Route of Administration (2016-2032)
      • Table 5: Global Influenza Vaccine Market Comparison by Distribution Channel (2016-2032)
      • Table 6: Global Influenza Vaccine Market Revenue (US$ Mn) Comparison by Region (2016-2032)
      • Table 7: Global Influenza Vaccine Market Revenue (US$ Mn) (2016-2032)
      • Table 8: Global Influenza Vaccine Market Revenue (US$ Mn) Comparison by Region (2016-2032)
      • Table 9: Global Influenza Vaccine Market Revenue (US$ Mn) Comparison by Type (2016-2032)
      • Table 10: Global Influenza Vaccine Market Revenue (US$ Mn) Comparison by Valency (2016-2032)
      • Table 11: Global Influenza Vaccine Market Revenue (US$ Mn) Comparison by Age Group (2016-2032)
      • Table 12: Global Influenza Vaccine Market Revenue (US$ Mn) Comparison by Route of Administration (2016-2032)
      • Table 13: Global Influenza Vaccine Market Revenue (US$ Mn) Comparison by Distribution Channel (2016-2032)
      • Table 14: Global Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Region (2016-2032)
      • Table 15: Global Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
      • Table 16: Global Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Valency (2016-2032)
      • Table 17: Global Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Age Group (2016-2032)
      • Table 18: Global Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Route of Administration (2016-2032)
      • Table 19: Global Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Distribution Channel (2016-2032)
      • Table 20: Global Influenza Vaccine Market Share Comparison by Region (2016-2032)
      • Table 21: Global Influenza Vaccine Market Share Comparison by Type (2016-2032)
      • Table 22: Global Influenza Vaccine Market Share Comparison by Valency (2016-2032)
      • Table 23: Global Influenza Vaccine Market Share Comparison by Age Group (2016-2032)
      • Table 24: Global Influenza Vaccine Market Share Comparison by Route of Administration (2016-2032)
      • Table 25: Global Influenza Vaccine Market Share Comparison by Distribution Channel (2016-2032)
      • Table 26: North America Influenza Vaccine Market Comparison by Valency (2016-2032)
      • Table 27: North America Influenza Vaccine Market Comparison by Age Group (2016-2032)
      • Table 28: North America Influenza Vaccine Market Comparison by Route of Administration (2016-2032)
      • Table 29: North America Influenza Vaccine Market Comparison by Distribution Channel (2016-2032)
      • Table 30: North America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Table 31: North America Influenza Vaccine Market Revenue (US$ Mn) (2016-2032)
      • Table 32: North America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Table 33: North America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Type (2016-2032)
      • Table 34: North America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Valency (2016-2032)
      • Table 35: North America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Age Group (2016-2032)
      • Table 36: North America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Route of Administration (2016-2032)
      • Table 37: North America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Distribution Channel (2016-2032)
      • Table 38: North America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
      • Table 39: North America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
      • Table 40: North America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Valency (2016-2032)
      • Table 41: North America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Age Group (2016-2032)
      • Table 42: North America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Route of Administration (2016-2032)
      • Table 43: North America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Distribution Channel (2016-2032)
      • Table 44: North America Influenza Vaccine Market Share Comparison by Country (2016-2032)
      • Table 45: North America Influenza Vaccine Market Share Comparison by Type (2016-2032)
      • Table 46: North America Influenza Vaccine Market Share Comparison by Valency (2016-2032)
      • Table 47: North America Influenza Vaccine Market Share Comparison by Age Group (2016-2032)
      • Table 48: North America Influenza Vaccine Market Share Comparison by Route of Administration (2016-2032)
      • Table 49: North America Influenza Vaccine Market Share Comparison by Distribution Channel (2016-2032)
      • Table 50: Western Europe Influenza Vaccine Market Comparison by Type (2016-2032)
      • Table 51: Western Europe Influenza Vaccine Market Comparison by Valency (2016-2032)
      • Table 52: Western Europe Influenza Vaccine Market Comparison by Age Group (2016-2032)
      • Table 53: Western Europe Influenza Vaccine Market Comparison by Route of Administration (2016-2032)
      • Table 54: Western Europe Influenza Vaccine Market Comparison by Distribution Channel (2016-2032)
      • Table 55: Western Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Table 56: Western Europe Influenza Vaccine Market Revenue (US$ Mn) (2016-2032)
      • Table 57: Western Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Table 58: Western Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Type (2016-2032)
      • Table 59: Western Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Valency (2016-2032)
      • Table 60: Western Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Age Group (2016-2032)
      • Table 61: Western Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Route of Administration (2016-2032)
      • Table 62: Western Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Distribution Channel (2016-2032)
      • Table 63: Western Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
      • Table 64: Western Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
      • Table 65: Western Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Valency (2016-2032)
      • Table 66: Western Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Age Group (2016-2032)
      • Table 67: Western Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Route of Administration (2016-2032)
      • Table 68: Western Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Distribution Channel (2016-2032)
      • Table 69: Western Europe Influenza Vaccine Market Share Comparison by Country (2016-2032)
      • Table 70: Western Europe Influenza Vaccine Market Share Comparison by Type (2016-2032)
      • Table 71: Western Europe Influenza Vaccine Market Share Comparison by Valency (2016-2032)
      • Table 72: Western Europe Influenza Vaccine Market Share Comparison by Age Group (2016-2032)
      • Table 73: Western Europe Influenza Vaccine Market Share Comparison by Route of Administration (2016-2032)
      • Table 74: Western Europe Influenza Vaccine Market Share Comparison by Distribution Channel (2016-2032)
      • Table 75: Eastern Europe Influenza Vaccine Market Comparison by Type (2016-2032)
      • Table 76: Eastern Europe Influenza Vaccine Market Comparison by Valency (2016-2032)
      • Table 77: Eastern Europe Influenza Vaccine Market Comparison by Age Group (2016-2032)
      • Table 78: Eastern Europe Influenza Vaccine Market Comparison by Route of Administration (2016-2032)
      • Table 79: Eastern Europe Influenza Vaccine Market Comparison by Distribution Channel (2016-2032)
      • Table 80: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Table 81: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) (2016-2032)
      • Table 82: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Table 83: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Type (2016-2032)
      • Table 84: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Valency (2016-2032)
      • Table 85: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Age Group (2016-2032)
      • Table 86: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Route of Administration (2016-2032)
      • Table 87: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Distribution Channel (2016-2032)
      • Table 88: Eastern Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
      • Table 89: Eastern Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
      • Table 90: Eastern Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Valency (2016-2032)
      • Table 91: Eastern Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Age Group (2016-2032)
      • Table 92: Eastern Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Route of Administration (2016-2032)
      • Table 93: Eastern Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Distribution Channel (2016-2032)
      • Table 94: Eastern Europe Influenza Vaccine Market Share Comparison by Country (2016-2032)
      • Table 95: Eastern Europe Influenza Vaccine Market Share Comparison by Type (2016-2032)
      • Table 96: Eastern Europe Influenza Vaccine Market Share Comparison by Valency (2016-2032)
      • Table 97: Eastern Europe Influenza Vaccine Market Share Comparison by Age Group (2016-2032)
      • Table 98: Eastern Europe Influenza Vaccine Market Share Comparison by Route of Administration (2016-2032)
      • Table 99: Eastern Europe Influenza Vaccine Market Share Comparison by Distribution Channel (2016-2032)
      • Table 100: APAC Influenza Vaccine Market Comparison by Type (2016-2032)
      • Table 101: APAC Influenza Vaccine Market Comparison by Valency (2016-2032)
      • Table 102: APAC Influenza Vaccine Market Comparison by Age Group (2016-2032)
      • Table 103: APAC Influenza Vaccine Market Comparison by Route of Administration (2016-2032)
      • Table 104: APAC Influenza Vaccine Market Comparison by Distribution Channel (2016-2032)
      • Table 105: APAC Influenza Vaccine Market Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Table 106: APAC Influenza Vaccine Market Revenue (US$ Mn) (2016-2032)
      • Table 107: APAC Influenza Vaccine Market Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Table 108: APAC Influenza Vaccine Market Revenue (US$ Mn) Comparison by Type (2016-2032)
      • Table 109: APAC Influenza Vaccine Market Revenue (US$ Mn) Comparison by Valency (2016-2032)
      • Table 110: APAC Influenza Vaccine Market Revenue (US$ Mn) Comparison by Age Group (2016-2032)
      • Table 111: APAC Influenza Vaccine Market Revenue (US$ Mn) Comparison by Route of Administration (2016-2032)
      • Table 112: APAC Influenza Vaccine Market Revenue (US$ Mn) Comparison by Distribution Channel (2016-2032)
      • Table 113: APAC Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
      • Table 114: APAC Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
      • Table 115: APAC Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Valency (2016-2032)
      • Table 116: APAC Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Age Group (2016-2032)
      • Table 117: APAC Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Route of Administration (2016-2032)
      • Table 118: APAC Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Distribution Channel (2016-2032)
      • Table 119: APAC Influenza Vaccine Market Share Comparison by Country (2016-2032)
      • Table 120: APAC Influenza Vaccine Market Share Comparison by Type (2016-2032)
      • Table 121: APAC Influenza Vaccine Market Share Comparison by Valency (2016-2032)
      • Table 122: APAC Influenza Vaccine Market Share Comparison by Age Group (2016-2032)
      • Table 123: APAC Influenza Vaccine Market Share Comparison by Route of Administration (2016-2032)
      • Table 124: APAC Influenza Vaccine Market Share Comparison by Distribution Channel (2016-2032)
      • Table 125: Latin America Influenza Vaccine Market Comparison by Type (2016-2032)
      • Table 126: Latin America Influenza Vaccine Market Comparison by Valency (2016-2032)
      • Table 127: Latin America Influenza Vaccine Market Comparison by Age Group (2016-2032)
      • Table 128: Latin America Influenza Vaccine Market Comparison by Route of Administration (2016-2032)
      • Table 129: Latin America Influenza Vaccine Market Comparison by Distribution Channel (2016-2032)
      • Table 130: Latin America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Table 131: Latin America Influenza Vaccine Market Revenue (US$ Mn) (2016-2032)
      • Table 132: Latin America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Table 133: Latin America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Type (2016-2032)
      • Table 134: Latin America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Valency (2016-2032)
      • Table 135: Latin America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Age Group (2016-2032)
      • Table 136: Latin America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Route of Administration (2016-2032)
      • Table 137: Latin America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Distribution Channel (2016-2032)
      • Table 138: Latin America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
      • Table 139: Latin America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
      • Table 140: Latin America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Valency (2016-2032)
      • Table 141: Latin America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Age Group (2016-2032)
      • Table 142: Latin America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Route of Administration (2016-2032)
      • Table 143: Latin America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Distribution Channel (2016-2032)
      • Table 144: Latin America Influenza Vaccine Market Share Comparison by Country (2016-2032)
      • Table 145: Latin America Influenza Vaccine Market Share Comparison by Type (2016-2032)
      • Table 146: Latin America Influenza Vaccine Market Share Comparison by Valency (2016-2032)
      • Table 147: Latin America Influenza Vaccine Market Share Comparison by Age Group (2016-2032)
      • Table 148: Latin America Influenza Vaccine Market Share Comparison by Route of Administration (2016-2032)
      • Table 149: Latin America Influenza Vaccine Market Share Comparison by Distribution Channel (2016-2032)
      • Table 150: Middle East & Africa Influenza Vaccine Market Comparison by Type (2016-2032)
      • Table 151: Middle East & Africa Influenza Vaccine Market Comparison by Valency (2016-2032)
      • Table 152: Middle East & Africa Influenza Vaccine Market Comparison by Age Group (2016-2032)
      • Table 153: Middle East & Africa Influenza Vaccine Market Comparison by Route of Administration (2016-2032)
      • Table 154: Middle East & Africa Influenza Vaccine Market Comparison by Distribution Channel (2016-2032)
      • Table 155: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Table 156: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) (2016-2032)
      • Table 157: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Table 158: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) Comparison by Type (2016-2032)
      • Table 159: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) Comparison by Valency (2016-2032)
      • Table 160: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) Comparison by Age Group (2016-2032)
      • Table 161: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) Comparison by Route of Administration (2016-2032)
      • Table 162: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) Comparison by Distribution Channel (2016-2032)
      • Table 163: Middle East & Africa Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
      • Table 164: Middle East & Africa Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
      • Table 165: Middle East & Africa Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Valency (2016-2032)
      • Table 166: Middle East & Africa Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Age Group (2016-2032)
      • Table 167: Middle East & Africa Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Route of Administration (2016-2032)
      • Table 168: Middle East & Africa Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Distribution Channel (2016-2032)
      • Table 169: Middle East & Africa Influenza Vaccine Market Share Comparison by Country (2016-2032)
      • Table 170: Middle East & Africa Influenza Vaccine Market Share Comparison by Type (2016-2032)
      • Table 171: Middle East & Africa Influenza Vaccine Market Share Comparison by Valency (2016-2032)
      • Table 172: Middle East & Africa Influenza Vaccine Market Share Comparison by Age Group (2016-2032)
      • Table 173: Middle East & Africa Influenza Vaccine Market Share Comparison by Route of Administration (2016-2032)
      • Table 174: Middle East & Africa Influenza Vaccine Market Share Comparison by Distribution Channel (2016-2032)
  • settingsSettings

Related Reports

Our Clients

  • Our Clients
Inquiry Before Buying

Influenza Vaccine Market
  • 57384
  • July 2024
    • ★★★★★
      ★★★★★
    • (34)
add_shopping_cart Buy Now
Trusted by more than 17382 organizations globally
  • Client Logo
  • Client Logo
  • Client Logo
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$6,000
$3,999
USD / per unit
save 24%
Multi User
$8,000
$5,999
USD / per unit
save 28%
Corporate User
$10,000
$6,999
USD / per unit
save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 3,999) Buy Now ($ 5,999) Buy Now ($ 6,999)
Find Help
Legal
Explore
Secured Payment Options
Secured Payment Options